Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Mirum Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.45 | -$0.13 | -$0.31 |
| Q2 2025 | 2 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2025 | 2 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2025 | 2 | -$0.17 | -$0.17 | -$0.17 |
| Q1 2026 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2026 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
Mirum Pharmaceuticals, Inc. Earnings Date And Information
Mirum Pharmaceuticals, Inc. last posted its earnings results on Wednesday, February 26th, 2025. The company reported $-0.49 earnings per share for the quarter, missing analysts' consensus estimates of $-0.27 by $0.22. The company had revenue of 99.41 M for the quarter and had revenue of 336.89 M for the year. Mirum Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-1.85 diluted earnings per share) and currently has a price-to-earnings ratio of -21.76. Mirum Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based on prior year's report dates.
Mirum Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/26/2025 | Q4 2024 | -$0.27 | -$0.49 | -0.22 | $96.61 M | $99.41 M |
| 11/12/2024 | Q3 2024 | -$0.45 | -$0.30 | 0.15 | $81.99 M | $90.38 M |
| 08/07/2024 | Q2 2024 | -$0.48 | -$0.52 | -0.04 | $75.03 M | $77.88 M |
| 05/08/2024 | Q1 2024 | -$0.40 | -$0.54 | -0.14 | $70.13 M | $69.22 M |
| 03/15/2024 | Q4 2023 | N/A | -$0.71 | N/A | $67.87 M | $69.55 M |
| 11/02/2023 | Q3 2023 | -$0.64 | -$0.57 | 0.07 | $38.60 M | $47.73 M |
| 08/07/2023 | Q2 2023 | N/A | -$1.94 | N/A | $30.44 M | $37.50 M |
| 05/04/2023 | Q1 2023 | -$0.96 | -$0.80 | 0.16 | $28.69 M | $31.60 M |
| 03/08/2023 | Q4 2022 | -$0.98 | -$0.99 | -0.01 | $24.65 M | $27.91 M |
| 11/09/2022 | Q3 2022 | -$1.05 | -$1.02 | 0.03 | $20.81 M | $18.78 M |
| 08/04/2022 | Q2 2022 | -$1.05 | -$0.84 | 0.21 | $15.42 M | $17.48 M |
| 05/05/2022 | Q1 2022 | -$1.39 | -$1.17 | 0.22 | $8.46 M | $12.89 M |
| 03/09/2022 | Q4 2021 | -$0.61 | $1.88 | 2.49 | $62.67 M | $3.14 M |
| 11/15/2021 | Q3 2021 | -$1.63 | -$1.55 | 0.08 | $1.00 M | $5.00 M |
| 08/05/2021 | Q2 2021 | -$0.41 | -$1.45 | -1.04 | $17.40 M | $11.00 M |
| 05/06/2021 | Q1 2021 | -$0.67 | -$1.68 | -1.01 | $12.50 M | $0 |
| 03/09/2021 | Q4 2020 | -$0.57 | -$1.43 | -0.86 | $10.00 M | $0 |
| 11/12/2020 | Q3 2020 | -$0.99 | -$0.86 | 0.13 | N/A | $0 |
| 08/06/2020 | Q2 2020 | -$0.88 | -$0.93 | -0.05 | N/A | $0 |
| 05/07/2020 | Q1 2020 | -$0.81 | -$0.86 | -0.05 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mirum Pharmaceuticals, Inc. Earnings: FAQ's
Mirum Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based offlast year's report dates.
The conference call for Mirum Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Mirum Pharmaceuticals, Inc.'s latest earnings report can be read online.
Mirum Pharmaceuticals, Inc. (:MIRM) has a recorded annual revenue of $336.89 M.
Mirum Pharmaceuticals, Inc. (:MIRM) has a recorded net income of $-87,942,000.Mirum Pharmaceuticals, Inc. has generated $-1.85 earnings per share over the last four quarters.
Mirum Pharmaceuticals, Inc. (:MIRM) has a price-to-earnings ratio of -21.76 and price/earnings-to-growth ratio is -2.05.